Drug Approval | August 17, 2021
Caplin Point Lab's subsidiary receives nod from Brazil's ANVISA for sterile injectable manufacturing site
The approval allows it to market its products in the country
The approval allows it to market its products in the country
Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant
This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology
This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
The Subsidiary has received one inspectional observation in Form 483
Alembic Pharmaceuticals commissions new facility at Pithampur
The inspection concluded with 6 observations and none of them were related to Data Integrity
Delivers robust earnings performance, successfully navigating a dynamic environment
The closing of the Block Acquisition is now expected to be completed by Q3 2025
Subscribe To Our Newsletter & Stay Updated
